
Senior Research Associate
Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.
- Test, maintain, and troubleshoot robotic platforms and laboratory automation instruments to execute biological protocols for antibody developability and functional genomics products.
- Collaborate with scientists to transfer manual processes to automated liquid handler workflows, validate, and execute them.
- Execute experiments to validate the quality and performance of laboratory automation systems, troubleshoot issues, and implement improvements.
- Provide technical training and support to laboratory personnel on automation processes, equipment, and technologies.
- Maintain and support safe lab practices and ensure quality control of instrumentation performance.
- Work independently and in an agile manner to complete tasks or projects within designated timelines.
Preferred Capabilities and Experience
-
BS or MS in biology, biochemistry, bioengineering, pharmacology, or related fields.
-
3-5 years of experience in an industry laboratory setting, ideally with lab automation or high-throughput screening.
-
Experience with lab automation (e.g., HRB workcells, Prime, Lynx, Hamilton).
-
Hands-on experience with mammalian cell culture, including assay development. Flow cytometry, or high-content imaging experience is a plus.
-
Strong troubleshooting skills and ability to efficiently resolve issues with automated systems while quickly adapting to evolving technology and assay methodology.
-
Ability to work in a dynamic environment with a sense of urgency, creativity, and focus on deliverables.
- What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)
- Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)
- Ginkgo Bioworks CEO on scaling up Covid-19 testing: ‘If we try, we can win’ (CNBC)
- Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities (Boston Globe)
- Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)
- Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response (PRNewswire)
- The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)
- Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)
- Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)
- Can This Company Convince You to Love GMOs? (The Atlantic)
Apply for this job
*
indicates a required field